The Inflation Reduction Act – Implications for Biopharma Companies and Patients

Incubate will be featuring DLA Piper for a webinar highlighting the drug pricing and access provisions of the Inflation Reduction Act.

The conversation will focus on the state of play around drug price controls and Medicare Part D; the key health provisions of the Inflation Reduction Act; downstream implications of the legislation; and then will conclude with a Q&A session.

Register Here: https://us06web.zoom.us/webinar/register/WN_CH7wep7NQYqI1EkVPAuhbw